leisure time -WSS

leisure time

author：Wikipedia 2025-10-06 19:20:41 - browse：5993

A medical insurance document printed with the words "COPAY," "DEDUCTIBLE," "COINSURANCE," "NON-COVERED," next to a pen — coverage from STAT — Adobe

WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending caps in most cases, after a Biden move in federal court on Tuesday.

Drug companies use copay coupons to help patients cover the cost of their drugs.

Before now, when drug companies helped patients pay their share of drug costs, insurers often didn’t count that assistance toward deductibles and out-of-pocket limits. In insurance jargon, this tactic is called a copay accumulator. Previously, the practice was only allowed when drug companies give coinsurance assistance for brand drugs with generic competition. The Trump administration let insurers use the tactic when cheaper generics were not available.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Humana sues Biden admin over Medicare Advantage audit rule

hotspot

focus

WSS

Listen: Biogen's potential pivot, & Illumina's next chapter

$1 billion proposal to grow Boston, Massachusetts biotech

'Make People Better': The CRISPR babies story you probably don't know

Why Talkspace is targeting Medicare, a tricky market

Longer MASH drug regimen improved liver, Akero study finds

Humana sues Biden admin over Medicare Advantage audit rule

entertainment

leisure time

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

AstraZeneca chief proposes a novel edit to the drug pricing bill

Psychedelics group wrestles with new pharma identity

Ethical issues complicate the benefits of medical crowdfunding

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Harvard's David Sinclair gets blowback over aging

The high cost of giving birth even with insurance

How generative AI is inspiring dreams of a health data revolution

How to save PrEP access — and even expand it

Illumina names Agilent executive as new CEO

entertainment

Longer MASH drug regimen improved liver, Akero study finds

Snackable artificial intelligence, expert AI, and the pharma industry

IVF doctors demand details after CooperSurgical lawsuit

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Why Novartis is changing the name of its research labs

Why Novartis is changing the name of its research labs

hotspot

hotspot

focus

entertainment